Intervacc is trading at €0.09, down 3.4% today, with no clear catalyst following recent thin price action and routine volatility.
- The stock has been fluctuating within a narrow range of €0.09–0.10 with no fresh company announcements, earnings, or regulatory headlines.
- Major financial data providers report no significant news for the company over the past two years, suggesting the move is driven by technical factors.
- As a small-cap biotech firm, the stock remains subject to high volatility despite the lack of fundamental news drivers.